Top Story

Physician-researcher joins City of Hope

March 5, 2015

Guido Marcucci, MD, a renowned physician and researcher, has accepted a leadership appointment at City of Hope’s new Hematologic Malignancies and Stem Cell Transplantation Institute.

Marcucci will serve as director of the Gehr Family Center for Leukemia Research, as well as chief of the division of hematopoietic stem cell and leukemia research.

Industry News

NCI director to step down March 31

March 5, 2015
Harold Varmus, MD, who has served as director of the NCI for the past 5 years, will step down at the end of this month.“I take this step with a mixture of regret…
Zhiyuan Zheng, PhD In the Journals

Despite clinical success, laparoscopic colectomy underused in colon cancer treatment

March 5, 2015
Laparoscopic colectomy has shown superiority in clinical trials to open colectomy, but most physicians still choose open resection as the standard of surgical care for…

SCOTUS hears arguments over tax credits for subsidies under ACA

March 4, 2015
The U.S. Supreme Court today began hearing oral arguments in King vs. Burwell, a case that will determine whether the Internal Revenue Service may extend tax-credit…

Bortezomib-based therapy improves outcomes, increases toxicity in mantle cell lymphoma

March 4, 2015
The substitution of bortezomib for vincristine in front-line therapy for mantle cell lymphoma was associated with prolonged PFS and higher response rates, according to…
More News Headlines »
Activity cover

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
thumbnail for video 4040847621001

MET targeting, PD-L1/PD-1 inhibition highlight recent developments in genitourinary oncology

February 11, 2015
Derek Raghavan, MD, PhD, FACP, FRACP, FASCO, president of Levine Cancer Institute at Carolinas HealthCare System and…
More »
High Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 2 High Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »